Ingaba i-OTC i-Products Asthma Products Safe?
Ulawulo lwezoKutya kunye neDrug (i-FDA) lutsha lukhuphe ukukhathazeka kwe-Asthmanefrin ngokubhekiselele kwimveliso yamanqaku esetyenziselwa ukuphucula okwethutyana iimpawu zesifo se-asthma. Kwileta ethunyelwe kwinkampani, i-FDA ithi inkampani kufuneka iphendule kwiinkxalabo kwaye inike icebo malunga nendlela ilungiselela ngayo ukujongana neengxaki.
Oku kudala ukuxhatshazwa kwenene koogqirha, izigulane kunye ne-FDA.
Izigulane ezininzi azizinayo i-inshorensi yempilo ebenza ukuba bakwazi ukufumana unyango rhoqo kwaye bajonge kwii-OTC iziyobisi ukuze bahlangabezane neemfuno zezempilo. Ngenxa yokuba i-asthma eqhelekileyo, isabelo esikhulu se-uninsured okanye phantsi kwezigulane eziqinisekisiwe ziya kuba ne-asthma. I-FDA inomsebenzi wokuqinisekisa ukuba iziyobisi zihlolwe ngokufanelekileyo ukukhusela nokusebenza. Oogqirha bahlala bebekwe phakathi kunye nokujongana nokunyamekelwa kwabantu ngabanye.
Ukongeza kwiinkxalabo zokhuseleko nazo zixhalaba malunga nokuba iimveliso ze-OTC zisebenza ngendlela efanelekileyo njengendlela yokhetho.
Ziziphi iingxaki zoKhuseleko lwe-Asthmanefrin?
I-Asthmanefrin yakhululwa ngoSeptemba 2012 emva kwexesha apho kwakungabikho kwii-counter counter-asthma ngenxa yokukhathazeka kwemeko ngenxa ye- CFC kwi-inhalers endala. Kwiingxelo zabo, i-FDA ikhankanyile iziganeko ezingabonakaliyo ukusuka kwi-Asthmanefrin ekhutshiwe kuquka:
- isicupunu (ukuziva ugula esiswini sakho)
- ukuhlanza
- ukuphakanyiswa kwegazi
- ukwanda kwentliziyo
- i-hemoptysis (ukukhwehlela igazi ekhupha i-sputum ebomvu)
Ukongezelela, sele ikhunjulwe ngokukhawuleza ngenxa yengozi yokumelana ne-EZ Breathe Atomizers. Kukho inkxalabo yokuba i-washer ingakwazi ukukhutshwa ngexesha lokusetyenziswa.
Ukukhathazeka kokukhuseleko akuyona into entsha ngaphezu kwemveliso ye-asthma. Abagqirha kunye namaqela achaphazelekayo baye bachaza ngamachiza amaninzi ayengathengiswa ngenxa yomshukela ophezulu, isifo senhliziyo okanye iingxaki ze-cholesterol ngoko kutheni zifanele zifumane i-asthma?
Uphando olwangaphambili lubonise ukuba ii-OTC iimveliso ze-asthma zikhuselekile, kodwa ukuba ubuncinane omnye kwabahlanu basebenzisa izidakamizwa ze-otc akufanele kube. Ukongezelela, iimveliso ezifana ne-Asthmanefrin zidibaniswe kunye nokusetyenziswa kweenkonzo zamagqirha kunye neziyobisi ezifana ne-steroids engenayo inokuphucula ulawulo lwe-asthma . Ngokuqhelekileyo, ukuba ufuna nayiphi na uhlobo phezu kwesiqinisekiso sokuphikisa isifo se-asthma njengezibonakaliso kunokuba udinga ukubona ugqirha okanye unonophelo lwezempilo ukwenzela ukuba ezo zimpawu zihlolwe.
Yintoni i-Asthmanefrin kunye ne-EZ Breathe Atomizer?
I-Asthmanefrine i-racepinephrine yamanzi okanye i-epinephrin e-racemic epilphrine, xa isetyenziselwa i-EZ Breathe Atomizer, iguqulelwa ibe ngumphunga oqhubekayo ophazamiseka kwimiphunga.
I-FDA Ileta Elulekayo kwiNefron Pharmaceuticals Corporation
Ileta eyisixwayiso kubenzi be-Asthmanefrin ijolise kwiindawo eziliqela. Okokuqala, ileta eyisixwayiso ithi i-Asthmanefrin iyinqobo "yeziyobisi ezintsha" ezingavunywanga yi-FDA ngokukhusela nokusebenza phantsi kwenkqubo yesicelo esitsha seziyobisi.
I-FDA iphinda ithi inkampani ithengisa i-atomizer yayo yokusetyenziswa "eyahlukileyo kwindlela esetyenzisiweyo yesicatshulwa ngokusemthethweni kwisixhobo sohlobo lwesixhobo. "I-FDA iphinda ithi inkampani yezobisi iyenza amabango angalunganga kwiintengiso ezifana nebango elithi Asthmanefrin" yindlela eya kwi-Primatene Mist CFC Inhaler. "I-FDA ithi inkampani ayinayo nayiphi na idatha yokuxhasa ukuba iziyobisi ezi-2 zifaniswa. Ukongezelela, i-FDA ixhalabisa ukuba ukulahlekisa kungaholela ekusebenziseni kakubi izigulane ezine-asthma.
I-FDA ibonisa ezinye iinkxalabo zokhuseleko ezibandakanya ukuhlaselwa kwe-asthma ebulalayo kwileta eya kwinkampani.
Imiba exhalabisayo ngemali yemveliso ekhutheleyo inokuthenjwa ngokuzithemba kwizigulane ezisebenzisa i-inhaler kunye neziphumo ezicacileyo ezi zikhokelela kuyo. Ngokufanayo, ukuba isiguli sifumana amayeza amaninzi kukho ukukhathazeka malunga nemiphumo emibi yengqondo. >
Ndingenza ntoni
Ukuba ufuna ukusebenzisa i-counter-counter product njenge-Asthmanefrin kufuneka ubone ugqirha malunga neempawu zakho. I-asthma yimeko apho ungangena ngokukhawuleza. Ndixhalabele ukuba isigulane esisebenzisa imveliso ye-astcma iya kukhusela iiofisi zonyango kwaye ziphucule iimpawu ezingakumbi.
Ukuba kufuneka usebenzise i-inhaler kwaye usebenzisa ii-OTC iimveliso ngenxa yokukhathazeka kwezezimali, inkqubo yesibonelelo yesigulane exhaswe ngamakhampani amaninzi angakunceda ufumane amayeza e-asthma mahhala okanye ngexabiso elinciphise kakhulu. Isiqhelo sisoloko sisekelwe kwisidingo sokugqibela esishiya ezinye izigulane zam eziziva zifuna ukuba zihlala zibandayo xa zingafaneleki. Iinkqubo zinokuba nzima ukulawula nokuhamba ukuze ufune ukucela unontlalontle okanye umphathi wecala uncedo.
Imithombo
I-FDA Isexwayiso kwiNifron Pharmaceuticals Corp 9/24/13. Kufumaneka ngo-Ephreli 16, 2016.
Kuschner WG, Hankinson TC, Wong HC kunye ne-Blanc PD. Ukusetyenziswa kweMilondilator engekho yonyango Sebenzisa kwi-Asthma. I-1997: 112; 987-993.
UDickinson BD, Altman RD, iDechchman SD kunye neComputer HC. Ukhuseleko lwe-Over-Counter Counter Inhalers ye-Asthma. I-Chest 2000; 118; 522-526.